Cargando…

Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria

Many species of pathogenic bacteria damage tissue cells by secreting toxins that form pores in plasma membranes. Here we show that glucocorticoids increase the intrinsic protection of tissue cells against pore-forming toxins. Dexamethasone protected several cell types against the cholesterol-depende...

Descripción completa

Detalles Bibliográficos
Autores principales: Ormsby, Thomas J. R., Owens, Sian E., Turner, Matthew L., Cronin, James G., Bromfield, John J., Sheldon, I. Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938277/
https://www.ncbi.nlm.nih.gov/pubmed/36807406
http://dx.doi.org/10.1038/s42003-023-04568-w
_version_ 1784890594554806272
author Ormsby, Thomas J. R.
Owens, Sian E.
Turner, Matthew L.
Cronin, James G.
Bromfield, John J.
Sheldon, I. Martin
author_facet Ormsby, Thomas J. R.
Owens, Sian E.
Turner, Matthew L.
Cronin, James G.
Bromfield, John J.
Sheldon, I. Martin
author_sort Ormsby, Thomas J. R.
collection PubMed
description Many species of pathogenic bacteria damage tissue cells by secreting toxins that form pores in plasma membranes. Here we show that glucocorticoids increase the intrinsic protection of tissue cells against pore-forming toxins. Dexamethasone protected several cell types against the cholesterol-dependent cytolysin, pyolysin, from Trueperella pyogenes. Dexamethasone treatment reduced pyolysin-induced leakage of potassium and lactate dehydrogenase, limited actin cytoskeleton alterations, reduced plasma membrane blebbing, and prevented cytolysis. Hydrocortisone and fluticasone also protected against pyolysin-induced cell damage. Furthermore, dexamethasone protected HeLa and A549 cells against the pore-forming toxins streptolysin O from Streptococcus pyogenes, and alpha-hemolysin from Staphylococcus aureus. Dexamethasone cytoprotection was not associated with changes in cellular cholesterol or activating mitogen-activated protein kinase (MAPK) cell stress responses. However, cytoprotection was dependent on the glucocorticoid receptor and 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR). Collectively, our findings imply that glucocorticoids could be exploited to limit tissue damage caused by pathogens secreting pore-forming toxins.
format Online
Article
Text
id pubmed-9938277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99382772023-02-19 Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria Ormsby, Thomas J. R. Owens, Sian E. Turner, Matthew L. Cronin, James G. Bromfield, John J. Sheldon, I. Martin Commun Biol Article Many species of pathogenic bacteria damage tissue cells by secreting toxins that form pores in plasma membranes. Here we show that glucocorticoids increase the intrinsic protection of tissue cells against pore-forming toxins. Dexamethasone protected several cell types against the cholesterol-dependent cytolysin, pyolysin, from Trueperella pyogenes. Dexamethasone treatment reduced pyolysin-induced leakage of potassium and lactate dehydrogenase, limited actin cytoskeleton alterations, reduced plasma membrane blebbing, and prevented cytolysis. Hydrocortisone and fluticasone also protected against pyolysin-induced cell damage. Furthermore, dexamethasone protected HeLa and A549 cells against the pore-forming toxins streptolysin O from Streptococcus pyogenes, and alpha-hemolysin from Staphylococcus aureus. Dexamethasone cytoprotection was not associated with changes in cellular cholesterol or activating mitogen-activated protein kinase (MAPK) cell stress responses. However, cytoprotection was dependent on the glucocorticoid receptor and 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR). Collectively, our findings imply that glucocorticoids could be exploited to limit tissue damage caused by pathogens secreting pore-forming toxins. Nature Publishing Group UK 2023-02-17 /pmc/articles/PMC9938277/ /pubmed/36807406 http://dx.doi.org/10.1038/s42003-023-04568-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ormsby, Thomas J. R.
Owens, Sian E.
Turner, Matthew L.
Cronin, James G.
Bromfield, John J.
Sheldon, I. Martin
Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
title Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
title_full Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
title_fullStr Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
title_full_unstemmed Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
title_short Glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
title_sort glucocorticoids increase tissue cell protection against pore-forming toxins from pathogenic bacteria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938277/
https://www.ncbi.nlm.nih.gov/pubmed/36807406
http://dx.doi.org/10.1038/s42003-023-04568-w
work_keys_str_mv AT ormsbythomasjr glucocorticoidsincreasetissuecellprotectionagainstporeformingtoxinsfrompathogenicbacteria
AT owenssiane glucocorticoidsincreasetissuecellprotectionagainstporeformingtoxinsfrompathogenicbacteria
AT turnermatthewl glucocorticoidsincreasetissuecellprotectionagainstporeformingtoxinsfrompathogenicbacteria
AT croninjamesg glucocorticoidsincreasetissuecellprotectionagainstporeformingtoxinsfrompathogenicbacteria
AT bromfieldjohnj glucocorticoidsincreasetissuecellprotectionagainstporeformingtoxinsfrompathogenicbacteria
AT sheldonimartin glucocorticoidsincreasetissuecellprotectionagainstporeformingtoxinsfrompathogenicbacteria